Ovarian Reserve
38
6
7
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.6%
1 terminated out of 38 trials
92.9%
+6.3% vs benchmark
16%
6 trials in Phase 3/4
0%
0 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 13 completed trials
Clinical Trials (38)
A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Female Fertility
Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO)
Ovarian Reserve After Laparoscopic Cystectomy for Endometriotic and Non-Endometriotic Cysts
AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer
Does Vnotes Salpingectomy Reduce Ovarian Reserve?
hCG Priming in Women With Diminished Ovarian Reserve
Extended LH Administration
SALpingectomy for STERilization (SALSTER)
Fertility and Ovarian Reserve in Female Childhood Cancer Survivors
In Vitro Maturation of Human Eggs
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
Clinical Efficacy of Acupuncture on the Liver Meridian in Women With Diminished Ovarian Reserve
Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.
hCG Priming in Women With Low Ovarian Reserve
Effects of Telomerase Reactivation With Danazol in Ovarian Function.
Assessment of Ovarian Reserve After Laparoscopic Cystectomy Versus Aspiration/Electrocoagulation in the Treatment of Ovarian Endometrioma
Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
Predictors of Ovarian Reserve in Infertile Women